Patent settlements.
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. Issues related to the launch of AbbVie's Hepatitis C drug.
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Corporate tax reform in general.
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Issues related to coverage and reimbursement of pharmaceuticals.
Duration: February 1, 2013
to
April 30, 2015
General Issues: Copyright/Patent/Trademark , Health Issues , Medical/Disease Research/Clinical Labs , Medicare/Medicaid , Taxation/Internal Revenue Code , Trade (Domestic & Foreign) , Pharmacy
Spending: about $450,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Justin McCarthy Legislative Correspondent, Rep. Thomas Ewing
Legislative Assistant, Rep. Thomas Ewing
Assist. USTR, Intergovernmental and Pub. Affairs
Assistant USTR, Congressional Affairs
Special Assistant to the President, Leg. Affairs
Jonathon Jones Legislative Director, Senator Carper
John Michael Gonzalez Chief of Staff, Rep. Chris Bell
Chief of Staff, Rep. Melissa Bean
Andrew McKechnie Health Policy Advisor, Sen. Finance Committee
Legislative Assistant, Senator Norm Coleman
Legislative Assistant, Rep. Jim Ramstad
Bipartisan Medical Technology Caucus
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2015
Peck Madigan Jones terminated an engagement in which they represented AbbVie Inc. on July 20, 2015.
Original Filing: 300744802.xml
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. Issues related to the launch of AbbVie's Hepatitis C drug.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Peck Madigan Jones lobbied for AbbVie Inc. , earning $50,000. The report was filed on April 20, 2015.
Original Filing: 300727332.xml
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. Issues related to the launch of AbbVie's Hepatitis C drug.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Peck Madigan Jones lobbied for AbbVie Inc. , earning $50,000. The report was filed on Jan. 20, 2015.
Original Filing: 300705371.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. H.R. 3723, Viral Hepatitis Testing Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, Peck Madigan Jones lobbied for AbbVie Inc. , earning $50,000. The report was filed on Oct. 20, 2014.
Original Filing: 300685847.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. H.R. 3723, Viral Hepatitis Testing Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, Peck Madigan Jones lobbied for AbbVie Inc. , earning $50,000. The report was filed on July 21, 2014.
Original Filing: 300667057.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. H.R. 3723, Viral Hepatitis Testing Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, Peck Madigan Jones lobbied for AbbVie Inc. , earning $50,000. The report was filed on April 21, 2014.
Original Filing: 300646333.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. H.R. 3723, Viral Hepatitis Testing Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Peck Madigan Jones lobbied for AbbVie Inc. , earning $50,000. The report was filed on Jan. 21, 2014.
Original Filing: 300622751.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. H.R. 3204, Drug Quality and Security Act.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Peck Madigan Jones lobbied for AbbVie Inc. , earning $50,000. The report was filed on Oct. 21, 2013.
Original Filing: 300603967.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. H.R. 3204, Drug Quality and Security Act.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Peck Madigan Jones lobbied for AbbVie Inc. , earning $50,000. The report was filed on July 22, 2013.
Original Filing: 300582723.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Peck Madigan Jones lobbied for AbbVie Inc. , earning $30,000. The report was filed on April 22, 2013.
Original Filing: 300561676.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
Peck Madigan Jones filed a lobbying registration on March 13, 2013 to represent AbbVie Inc., effective Feb. 1, 2013.
Original Filing: 300546376.xml
Issue(s) they said they’d lobby about: Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. Corporate tax reform in general. Issues related to the Trans-Pacific Partnership. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...